Back to News
Market Impact: 0.2
Xcellerant Ventures Invests $1M in Geneticure to Advance Precision Medicine and Expand Arizona's Biotech Hub
Source: PR Newswire
Healthcare & BiotechPrivate Markets & VentureCompany Fundamentals
Xcellerant Ventures announced a $1 million Fund I investment in Geneticure, which plans to establish a clinical lab in Arizona and bring predictive testing for renal denervation to market. The brief announcement provides no further investment terms, timing, or clinical and commercial results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Why is Tesla stock falling after-hours today?
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal
- Zuckerberg told Meta directors he might leave California, where he could lose billions to a wealth tax. Meta answered with a new class of stock